Login / Signup

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients.

Gregory P BottaTridu R HuynhSamantha R Spierling-BagsicAlexander AgelidisRandolph SchafferRay LinDarren Sigal
Published in: Cancer medicine (2022)
BRPC and LAPC patients capable of surgery after only receiving neoadjuvant treatment with chemotherapy had higher rates of R0 resection with prolonged median PFS and OS compared with any patient needing combination chemotherapy with radiotherapy.
Keyphrases